• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解读成本效益研究的结果。

Interpreting the results of cost-effectiveness studies.

作者信息

Cohen David J, Reynolds Matthew R

机构信息

Saint Luke's Mid America Heart Institute, Kansas City, Missouri 64111, USA.

出版信息

J Am Coll Cardiol. 2008 Dec 16;52(25):2119-26. doi: 10.1016/j.jacc.2008.09.018.

DOI:10.1016/j.jacc.2008.09.018
PMID:19095128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2716087/
Abstract

In developed nations, health care spending is an increasingly important economic and political issue. The discipline of cost-effectiveness (CE) analysis has developed over several decades as a tool for objectively assessing the value of new medical strategies, by simultaneously examining incremental health benefits in light of incremental costs. The underlying goal of CE research is to allow clinicians and policymakers to make more rational decisions regarding clinical care and resource allocation. This review will provide the reader with an understanding of the theoretical underpinnings of CE analysis, the types of analyses commonly performed and reported in the medical literature, some important strengths and weaknesses of different analytical approaches, and key principles in the interpretation of CE results. Key principles reviewed include the impact of analytic perspective, the importance of proper incremental comparisons, the effect of time horizon, and methods for exploring and describing uncertainty. Illustrative examples from the cardiology literature are discussed.

摘要

在发达国家,医疗保健支出日益成为重要的经济和政治问题。成本效益(CE)分析学科在过去几十年中不断发展,成为一种通过结合增量成本来同时考察增量健康效益,从而客观评估新医疗策略价值的工具。CE研究的根本目标是让临床医生和政策制定者在临床护理和资源分配方面做出更合理的决策。本综述将使读者了解CE分析的理论基础、医学文献中常见的分析类型及报告方式、不同分析方法的一些重要优缺点,以及CE结果解读中的关键原则。所综述的关键原则包括分析视角的影响、恰当增量比较的重要性、时间范围的影响以及探索和描述不确定性的方法。文中还讨论了来自心脏病学文献的实例。

相似文献

1
Interpreting the results of cost-effectiveness studies.解读成本效益研究的结果。
J Am Coll Cardiol. 2008 Dec 16;52(25):2119-26. doi: 10.1016/j.jacc.2008.09.018.
2
Generalisability in economic evaluation studies in healthcare: a review and case studies.医疗保健经济评估研究中的可推广性:综述与案例研究
Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. doi: 10.3310/hta8490.
3
How to develop cost-conscious guidelines.如何制定注重成本的指南。
Health Technol Assess. 2001;5(16):1-69. doi: 10.3310/hta5160.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Economic foundations of cost-effectiveness analysis.成本效益分析的经济基础。
J Health Econ. 1997 Feb;16(1):1-31. doi: 10.1016/s0167-6296(96)00506-1.
6
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.五种预防非甾体抗炎药所致胃肠道毒性策略的成本效益比较:一项基于经济模型的系统评价
Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. doi: 10.3310/hta10380.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Statistical approaches to handling uncertainty in health economic evaluation.健康经济评估中处理不确定性的统计方法。
Eur J Gastroenterol Hepatol. 2004 Jun;16(6):551-61. doi: 10.1097/00042737-200406000-00007.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.与缺血性心肌病当前现有检测途径相比,心脏磁共振成像成本效益的系统评价与建模
Health Technol Assess. 2014 Sep;18(59):1-120. doi: 10.3310/hta18590.

引用本文的文献

1
Clinical and cost-effectiveness of pharmacogenomic testing for anthracycline-induced cardiotoxicity in childhood cancer: a systematic review and meta-analysis.儿童癌症中蒽环类药物所致心脏毒性的药物基因组学检测的临床及成本效益:一项系统评价和荟萃分析
Front Pharmacol. 2025 Jul 16;16:1568320. doi: 10.3389/fphar.2025.1568320. eCollection 2025.
2
Cost-effectiveness of adding measurement of Chlamydia trachomatis infection and serology to trachoma prevalence surveys in Tanzania and Mozambique.在坦桑尼亚和莫桑比克的沙眼患病率调查中增加沙眼衣原体感染检测及血清学检测的成本效益分析。
PLoS Negl Trop Dis. 2025 Jul 21;19(7):e0013257. doi: 10.1371/journal.pntd.0013257. eCollection 2025 Jul.
3
Health Economic Evaluations in Intensive Care: An Updated Systematic Review.重症监护中的卫生经济评估:一项更新的系统评价。
Crit Care Explor. 2025 Jul 16;7(7):e1288. doi: 10.1097/CCE.0000000000001288. eCollection 2025 Jul 1.
4
Economic Evaluations of Speech and Language Therapy Interventions: A Scoping Review.言语和语言治疗干预的经济学评估:一项范围综述
Int J Lang Commun Disord. 2025 Jul-Aug;60(4):e70091. doi: 10.1111/1460-6984.70091.
5
Cost-effectiveness of CPAP treatment in a tax-funded healthcare system - a scoping review and suggestions for cost reduction of CPAP treatment.税收资助医疗体系中持续气道正压通气治疗的成本效益——一项范围综述及持续气道正压通气治疗成本降低建议
Eur Clin Respir J. 2025 Jun 19;12(1):2518663. doi: 10.1080/20018525.2025.2518663. eCollection 2025.
6
Decision Analysis in the Management of Hip and Knee Osteoarthritis: A Systematic Review.髋膝关节骨关节炎管理中的决策分析:一项系统评价
Cureus. 2025 May 10;17(5):e83860. doi: 10.7759/cureus.83860. eCollection 2025 May.
7
Cost-Effectiveness of an Enhanced Patient Care Intervention for Improving Viral Suppression Among Kenyan Adults Living With HIV.一种强化患者护理干预措施对提高肯尼亚成年艾滋病毒感染者病毒抑制效果的成本效益分析
Value Health Reg Issues. 2025 May 21;49:101129. doi: 10.1016/j.vhri.2025.101129.
8
Cost-effectiveness of Semaglutide Compared With Other Glucose-Lowering Medications in Treating Type 2 Diabetes: A Comprehensive Systematic Review and Meta-analysis.司美格鲁肽与其他降糖药物治疗2型糖尿病的成本效益:一项全面的系统评价和荟萃分析。
Diabetes Care. 2025 Jun 1;48(6):1032-1041. doi: 10.2337/dc24-2241.
9
Integrating health care and early years support for children and young people living in deprivation: a cost-effectiveness analysis of the Sparkbrook Children's Zone integrated clinic versus usual primary care in Birmingham, UK.为生活在贫困地区的儿童和青少年整合医疗保健与早期支持:英国伯明翰Sparkbrook儿童社区综合诊所与常规初级医疗服务的成本效益分析
BMJ Paediatr Open. 2025 Apr 9;9(1):e003249. doi: 10.1136/bmjpo-2024-003249.
10
Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis.基于顺铂的围手术期化疗用于肌层浸润性膀胱癌:一项决策分析
World J Urol. 2025 Mar 30;43(1):197. doi: 10.1007/s00345-025-05584-7.

本文引用的文献

1
Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model.裸金属支架与药物洗脱支架再狭窄和支架血栓形成风险的权衡:决策分析模型的结果
J Am Coll Cardiol. 2008 May 13;51(19):1844-53. doi: 10.1016/j.jacc.2008.01.042.
2
Options for slowing the growth of health care costs.减缓医疗保健成本增长的方法。
N Engl J Med. 2008 Apr 3;358(14):1509-14. doi: 10.1056/NEJMsb0707912.
3
The use of economic evaluations in NHS decision-making: a review and empirical investigation.国民健康服务体系决策中经济评估的应用:一项综述与实证研究
Health Technol Assess. 2008 Apr;12(7):iii, ix-x, 1-175. doi: 10.3310/hta12070.
4
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.预算影响分析良好实践原则:ISPOR良好研究实践特别工作组——预算影响分析报告
Value Health. 2007 Sep-Oct;10(5):336-47. doi: 10.1111/j.1524-4733.2007.00187.x.
5
The value of medical spending in the United States, 1960-2000.1960年至2000年美国医疗支出的价值。
N Engl J Med. 2006 Aug 31;355(9):920-7. doi: 10.1056/NEJMsa054744.
6
Trends in the measurement of health utilities in published cost-utility analyses.已发表的成本效用分析中健康效用测量的趋势。
Value Health. 2006 Jul-Aug;9(4):213-8. doi: 10.1111/j.1524-4733.2006.00116.x.
7
Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.紫杉醇洗脱支架用于接受经皮冠状动脉血运重建患者的成本效益:TAXUS-IV试验结果
J Am Coll Cardiol. 2006 Jul 18;48(2):253-61. doi: 10.1016/j.jacc.2006.02.063. Epub 2006 Jun 22.
8
Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).除颤器治疗或胺碘酮用于慢性稳定型心力衰竭的成本效益:心力衰竭心脏性猝死试验(SCD-HeFT)的结果
Circulation. 2006 Jul 11;114(2):135-42. doi: 10.1161/CIRCULATIONAHA.105.581884. Epub 2006 Jul 3.
9
The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.植入式心脏复律除颤器的成本效益:多中心自动除颤器植入试验(MADIT-II)的结果。
J Am Coll Cardiol. 2006 Jun 6;47(11):2310-8. doi: 10.1016/j.jacc.2006.03.032. Epub 2006 May 4.
10
Cost effectiveness of cardiac resynchronization therapy.
J Am Coll Cardiol. 2005 Dec 20;46(12):2322-4. doi: 10.1016/j.jacc.2005.09.003.